International Cannabis Weekly: 53

• Financiers in London turn their eyes to the cannabis green rush.
• MGC Pharma secure European cannabis manufacturing license for facility in Slovenia.
• XHemplar Italia plants 25 acres of low THC ‘cannabis light’.
• Canopy Growth agrees to acquire Hiku Brands to strengthen retail portfolio.
• Together Pharma begins selling cannabis cosmetics containing Dead Sea minerals.
• Israeli cannabis producer Tefen finalises $23 million local sales deal.
• CannTrust receives license to export medical cannabis into Denmark.
• Pure Global Cannabis completes reverse takeover with PureSinse.

• Israeli government gives green light to cannabis decriminalisation bill.
• Netherlands begins pilot experiment into legal cannabis cultivation.
• French Health Minister states she is ’not against’ cannabis for medical purposes.
• MP calls British government’s handling of medical cannabis review ‘cruel and callous’.

• Lossless Activation revolutionise the edibles and extractions markets.
• Genetically modified cannabis is coming, but legal barriers still stand in its way.
• How cannabis can ease suffering of those living with arthritis.
• Can cannabis be considered a psychedelic drug?

• Lebanese minister considers financial benefits of legal cannabis cultivation and export.
• MYM acquires 49% stake in Colombia Organica.
• Majority Aboriginal-owned BeeHighVE to begin cannabis cultivation in Newfoundland.
• Indian Industrial Hemp Association granted licence to grow 1,000 hectares of hemp.

Prohibition Partners are pleased to announce the release of the 3rd Edition of The European Cannabis Report™. The report explores the medical, recreational, and industrial cannabis industries across 28 key European states. Identifying the commercial, legal, and social trends affecting the European market, the report provides a detailed analysis into what will become the world’s largest cannabis market.

The GMP Standards Guide’, in association with Orion GMP Solutions. The guide is used by manufacturers and legislators to understand the complex network of regulations that will shape the European cannabis market.